Hepatitis, Autoimmune

• 

  Subject Areas on Research

  • Autoimmune hepatitis in a child with chronic hepatitis B virus infection. 
  • Clinical features, outcomes, and HLA risk factors associated with nitrofurantoin-induced liver injury. 
  • Features of Autoimmune Hepatitis in Patients With Drug-induced Liver Injury. 
  • Immunosuppression in Autoimmune Hepatitis: Is There an End Game? 
  • Inflammatory bowel disease after liver transplantation: risk factors for recurrence and de novo disease. 
  • Inflammatory bowel disease following solid organ transplantation. 
  • Methylphenidate-induced autoimmune hepatitis. 
  • Nitrofurantoin-induced fulminant hepatitis mimicking autoimmune hepatitis. 
  • Noninvasive markers in the assessment and management of autoimmune liver diseases. 
  • Patients with autoimmune hepatitis who have antimitochondrial antibodies need long-term follow-up to detect late development of primary biliary cirrhosis. 
  • Reply to: Diagnostic role of anti-dsDNA antibodies: do not forget autoimmune hepatitis. 
  • Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network. 
  • The impact of human leukocyte antigen donor and recipient serotyping and matching on liver transplant graft failure in primary sclerosing cholangitis, autoimmune hepatitis, and primary biliary cholangitis. 
  • The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury. 
  • Use of tacrolimus in the treatment of autoimmune hepatitis: a single centre experience. 
  • Utility of thiopurine methyltransferase genotyping and phenotyping, and measurement of azathioprine metabolites in the management of patients with autoimmune hepatitis.